Another Shot at a Vaccine for Lyme Disease
The U.S. National Institutes of Health (NIH) has provided the University of Maryland with a $3.5 million dollar grant to develop a vaccine for Lyme disease.1 Principal investigators Utal Pal, PhD, professor at the Virginia-Maryland…
CONTINUE READINGFlu Shot Deaths in South Korea Said to Be “Coincidental”
Story Highlights More than 80 people have died in South Korea following influenza vaccination. After an investigation into the safety…
CureVac’s COVID-19 Vaccine Produces Grade 3 Adverse Events
Biopharmaceutical company CureVac NV of Tübingen, Germany has released the interim results of its Phase 1 clinical trial on its…
CDC Gives States COVID-19 Vaccination Program “Playbook”
The U.S. Centers for Disease Control (CDC) created a national COVID-19 Vaccine Program Playbook for state, territorial and local public…
Brazilian Doctor Dies Participating in AstraZeneca’s COVID-19 Vaccine Clinical Trial
Story Highlights A COVID-19 vaccine trial participant, who was a physician working with COVID-19 patients at hospitals in Brazil, has…
Half a Million Sharks Could Die to Produce Squalene Adjuvants for COVID-19 Vaccines
Story Highlights A shark conservation group is calling for alternatives to using squalene harvested from the liver of sharks as…
Moderna’s COVID-19 Vaccine Provokes ‘COVID-Like Symptoms’ in Phase 3 Trial
Biotechnology firm Moderna, Inc. of Cambridge, Massachusetts began a Phase 3 human clinical trial to test the safety and efficacy…